Marcelo Iastrebner
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ruxolitinib in the Treatment of Covid-19 (NCT04414098) | Marcelo Iastrebner | 2020-06-01 |
Track Marcelo Iastrebner automatically
Every clearance here is in the API, with alerts when new ones post.